EP2271280A1 - Covered stent and method of making - Google Patents

Covered stent and method of making

Info

Publication number
EP2271280A1
EP2271280A1 EP09728421A EP09728421A EP2271280A1 EP 2271280 A1 EP2271280 A1 EP 2271280A1 EP 09728421 A EP09728421 A EP 09728421A EP 09728421 A EP09728421 A EP 09728421A EP 2271280 A1 EP2271280 A1 EP 2271280A1
Authority
EP
European Patent Office
Prior art keywords
substrate
stent
covered stent
interwoven
covered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09728421A
Other languages
German (de)
French (fr)
Inventor
Trevor Greenan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Vascular Inc
Original Assignee
Medtronic Vascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Vascular Inc filed Critical Medtronic Vascular Inc
Publication of EP2271280A1 publication Critical patent/EP2271280A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/89Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining

Definitions

  • the invention relates to encapsulated stents suitable for placement in a human body lumen such as an artery.
  • Tubular prostheses such as stents, grafts, and stent-grafts (e.g., stents having an inner and/or outer covering comprising graft material and which may be referred to as covered stents) have been used to treat abnormalities in passageways in the human body.
  • these devices often are used to replace or bypass occluded, diseased or damaged blood vessels such as stenotic or aneurysmal vessels.
  • stent-grafts which comprise biocompatible graft material (e.g., Dacron ® or expanded polytetrafluoroethylene (ePTFE) or some other polymer) supported by a framework (e.g., one or more stent or stent-like structures), to treat or isolate aneurysms.
  • the framework provides mechanical support and the graft material or liner provides a blood barrier.
  • Aneurysms are an abnormal widening of a duct or canal such as a blood vessel and generally appear in the form of a sac formed by the abnormal dilation of the duct or vessel wall.
  • the abnormally dilated wall typically is weakened and susceptible to rupture.
  • Aneurysms can occur in blood vessels such as in the abdominal aorta where the aneurysm generally extends from a location below the renal arteries distally to or toward the iliac arteries.
  • the stent-graft In treating an aneurysm with a stent-graft, the stent-graft typically is placed so that one end of the stent-graft is situated proximally or upstream of the diseased portion of the vessel and the other end of the stent-graft is situated distally or downstream of the diseased portion of the vessel. In this manner, the stent-graft extends through (spans) the aneurysmal sac and beyond the proximal and distal ends thereof to replace or bypass the weakened portion.
  • the graft material typically forms a blood impervious lumen to facilitate endovascular exclusion of the aneurysm.
  • stent-grafts such as abdominal aortic aneurysm stent- grafts
  • sewing annular metallic spring elements which may have a sinusoidal configuration, to woven materials described above such as expanded polytetrafluoroethylene, polytetrafluoroethylene, or Dacron ® fabric.
  • Other approaches have included electrospinning the stent structure with a polymer or dip coating the stent structure with a polymer.
  • FIG. 1 One example of a known polymeric coated stent-graft is illustrated in FIG. 1 , where covered stent 100 comprises metallic springs or undulating elements 102a, 102b, 102c and 102d, which can be referred to as stents or stent elements.
  • stents or stent elements 102a, 102b, 102c and 102d have been treated with an electrospinning or dip coating process to form tubular polymeric graft member 104, which is adhered thereto.
  • electrospinning and dip coating techniques may provide stent-grafts with lower profiles, there is a relatively low contact surface area between the stents and the polymeric material and the line of contact or adhesion between the stent and the polymeric material also may not be uniform throughout the circumference of the stent resulting in non-uniform load distribution when a force is placed on the stent-graft, which can result in delamination.
  • FIG. 2 illustrates a covered stent 110 having a known construction including a plurality of metallic undulating annular stent elements 112a, 112b, 112c ...112n and annular undulating bare wire spring 116.
  • a known electrospinning or dip coating process is used to provide the stent elements with a tubular polymeric graft 114 and to secure the apexes at one end of bare spring 116 to the graft.
  • the apexes which can be subjected to higher stresses than the stent elements, can detach as diagrammatically shown for example with reference character D2.
  • a covered stent suitable for placement in a lumen in a human body comprises a substrate; a tubular stent adapted to be placed in a lumen of a human body, the stent having portions interwoven in the substrate; and encapsulation encapsulating the substrate and the portions of the stent interwoven in the and forming tubular graft member.
  • a covered stent suitable for placement in a lumen in a human body comprises a substrate; a plurality of stents adapted to be placed in a lumen of a human body, the stents having portions interwoven in the substrate; and a tubular polymeric member covering the stents and extending through at least a portion of the substrate.
  • a method of making a covered stent comprises interweaving a wire though a substrate to form a tubular member; and encapsulating the tubular member to form a covered stent having a tubular cover.
  • FIG. 1 illustrates a known covered stent configuration.
  • FIG. 2 illustrates a portion of another known covered stent configuration.
  • FIG. 3A is a cut away view of a covered stent embodiment according to the invention with a portion of the cover removed to show a stent element and a substrate in which it is integrated.
  • FIG. 3B1 is a sectional view taken along line 3B1-3B1 in FIG. 3A and diagrammatically illustrating locations in the tubular substrate where the annular stent is interwoven.
  • FIG. 3B2 is a sectional view taken through a portion of one of the stents of FIG. 3A showing the substrate and cover material
  • FIG. 3C is a close up view illustrating a variation of the substrate-stent configuration shown in FIG. 3A.
  • FIG. 3D is a close up view illustrating another variation of the substrate-stent configuration shown in FIG. 3A.
  • FIG. 4 is a close up view illustrating a stent-graft substrate and a bare wire spring integrated therein according to another embodiment of the invention.
  • FIG. 5A illustrates a known anchoring mechanism.
  • FIG. 5B illustrates a portion of a covered stent with the anchoring mechanism of FIG. 5A integrated therein.
  • FIG. 6 is a partial sectional view of a portion of a covered stent with an anchor element secured thereto.
  • FIG. 7 is a partial sectional view of a portion of a covered stent with an anchor element secured thereto.
  • FIGS. 8A and 8B illustrate assembly of another covered stent embodiment according to the invention, where FIG. 8A illustrates an anchoring attachment component for the covered stent and FIG. 8B illustrates the anchoring attachment component integrally formed in a covered stent according to another embodiment.
  • the invention generally involves a method of incorporating one or more stent and/or anchor structures into a polymeric membrane, which can be formed, for example, through known electrospinning or dip coating techniques.
  • the stent or stents or at least a portion thereof are integrally incorporated into a material, which can be referred to as a substrate, and the integrated construction partially or wholly encapsulated (e.g., in a polymer such as polyurethane) by known electrospinning or dip coating techniques.
  • the substrate material can be loose textile mesh constructed from an open weave, knit, or braid.
  • the textile mesh should be sufficiently open to easily allow the polymer to flow through it during the electrospinning or dip coating process.
  • incorporating or integrating the stent into the substrate material can be accomplished by passing an end of the stent wire back and forth through mesh in an annular direction and then crimping the free ends of the wire together to form an annular stent element. All of the wire need not be weaved in and out of the mesh as will be described in more detail below.
  • Other methods of integrating the stent and mesh material include weaving or knitting the mesh around the entire stent or at least a portion of the stent.
  • the integrated stent-substrate construction is then encapsulated or coated using, for example, a known stent electrospinning or dip coating process, to form the polymeric membrane stent cover.
  • the stent cover provides a fluid barrier that is suitable as for use as a graft in a lumen in a human patient. Typically the cover will provide a continuous blood impervious surface suitable for use in an artery in a human patient.
  • One of the many advantages of this construction is that if the stent becomes completely delaminated from the polymeric membrane formed with the foregoing process, it remains attached by the polymer mesh (polymer mesh is a loose weave, braid, or knit.
  • the substrate or mesh can better distribute the load of the stent through the membrane as compared to a stent without such a substrate.
  • the polymeric material also can be selected to improve the bonding or adhesion between the stent-substrate and the polymeric material.
  • the mesh substrate has a loose construction suitable for weaving the stent wire in and out of the substrate. It can be a very open weave, knit or braid. Knitted meshes typically offer more flexibility and weaves typically offer more dimensional stability.
  • the substrate mesh can be made from a variety of materials including polyester, UHMWPE, liquid crystal polymers, and Kevlar.
  • covered stent 200 is shown with three stents 202a, 202b and 202c. It should be understood, however, that more or fewer stents can be used.
  • the stents are shown with undulating annular configurations where each undulation has two leg portions which converge at an apex. The number of undulations can vary depending on the size of the stent and the application and in this example there are four undulations where two are hidden from view.
  • one of each of the two leg portions is interwoven into the material and the other is not woven into the material and is adjacent to the inner surface or outer surface of mesh substrate 206.
  • FIG. 3A depicts descending legs 208a and 208b interwoven in mesh substrate 206 in which appears as dashed lines, while ascending legs 209a and 209b are shown positioned along the outer surface of the substrate.
  • the other undulating portions are similarly integrated with mesh substrate 206, but hidden from view.
  • every other leg is interwoven into the substrate when moving in an annular or circumferential direction as diagrammatically shown in FIG. 3B1.
  • FIG. 3C an oppositely configured pattern is used.
  • Legs 209a, 209b, and 209c are interwoven into mesh substrate 206, while legs 208a, 208b, 208c are outside the mesh substrate prior to electrospinning or dip coating (the remaining legs forming the annular stent are hidden from view.
  • all legs of each undulation are interwoven into the mesh substrate before electrospinning or dip coating (five legs are shown in this figure with the remaining legs forming the annular stent being hidden from view).
  • FIG. 3B2 a sectional view of a portion of stent 200 is shown depicting stent wire 202c between two layers of polymeric material 204 on opposite sides of the mesh substrate.
  • the mesh substrate is sufficiently open so as to allow the polymer to pass therethrough during the electrospinning or dip coating process.
  • FIG. 4 another embodiment is shown where undulating bare spring wire 510 is integrated with mesh substrate 506 before electrospinning or dip coating.
  • the apex portions at one end of the bare spring are interwoven in mesh substrate 506.
  • the apex portions are shown encircled and numbered 512a, 512b, and 512c.
  • Stent elements can be provided as described in any of the embodiments disclosed herein.
  • FIG. 5A depicts a known stent-graft anchor 600 having a barb support member or cage 602 with a plurality of barbs 604a,b,c,d extending from or secured to end portions along one side thereof.
  • Wires or posts 606a,b,c,d having eyelets or loops 608a,b,c,d at their free ends extend from or are attached to the other side of the cage.
  • the anchor is secured to covered stent 650 having one or more stents 652 integrated therein using a substrate as described above.
  • the anchor is secured to the substrate with a plurality of high strength filaments 654a,b...n that are looped through eyelets 608a,b...n.
  • the filaments are interwoven in the substrate along a portion of the length of the substrate such as shown in detail in FIG. 6 before the stent, substrate and eyelets are encapsulated in a polymer by way of, for example, an electrospinning or dip coating process to provide a tubular covered stent that is impervious to blood flow through the tubular cover.
  • the substrate can run the entire length of the covered stent in this embodiment or any other embodiment described herein and the filaments can be interwoven along the entire length of the substrate to maximize filament incorporation or integration with the cover or polymeric membrane 656, which can comprise, for example, any of the materials described above.
  • the substrate need not run the entire length of the covered stent and the filaments need not extend the entire length of the substrate.
  • the free ends of the filament can be adhered, tied otherwise secured to the substrate.
  • Anchor 600 and the bare springs described below typically are attached to the proximal end of the covered stent, which is the end closest to the heart by reference to blood flow path when the covered stent is positioned in situ.
  • FIG. 6 another covered stent embodiment 700 is shown where a bare coil spring 750 with posts 752a,b,c...n extending therefrom and including eyelets 754a,b,c...n is secured to the covered stent in the same manner as anchor 600 is secured to covered stent 650.
  • Each of a plurality of high strength filaments 756a,b...n, each of which can be a high strength fiber, are passed through a respective eyelet and interwoven in the mesh substrate that extends the entire length and the entire circumference of the covered stent.
  • Covered stent 700 is shown in partial section with a portion of polymeric layer or cover 757 removed to show a portion of substrate 758 in an enlarged manner to illustrate filament 756b interwoven therein.
  • Substrate 758 has a plurality of interwoven threads that can be interlaced like the warp and weft of a woven fabric. It should be understood that mesh patterns in all of the embodiments described herein are interchangeable and further that other patterns can be used as the illustrative embodiments are provided for the purposes of example and not to limit the scope of of possible options.
  • Covered stent 700 also includes one or more stents 780 which can have the same configuration as stents 202a-c and can be interwoven into mesh substrate 758 in the same manner as stents 202a-c are interwoven into braid-type mesh substrate 206.
  • FIG. 7 another covered embodiment 800, which is the same as covered stent 700 with the exception that the securing filament pattern differs.
  • Bare spring 850 can have the same construction as bare spring 750 with eyelets 854a,b,c...n through which high strength filaments 856a,b,c...n are passed.
  • Filaments 856a, b, c... n are interwoven in substrate 858, which can have the same construction as substrate 758 or any other suitable substrate.
  • Covered stent 800 is shown in partial section with a portion of polymeric layer or cover 857 removed to show a portion of substrate 858 in an enlarged manner to illustrate filaments 856a and 856c interwoven therein.
  • each filament has one portion that extends in a clockwise helical direction and another portion that extends in a counterclockwise helical direction.
  • the filaments in this embodiment can improve load distribution from the eyelets.
  • covered stent 800 also includes one or more stents, which can have the same configuration as stents 202a-c and can be interwoven into mesh substrate 858 in the same manner as stents 202a-c are interwoven into braid-type mesh substrate 206.
  • FIGS. 8A and 8B another covered stent embodiment 900 according to the invention is shown, where FIG. 8A illustrates an anchor and attachment component of covered stent 900 and FIG.
  • bare spring 950 has the same construction as bare spring 750 and includes eyelets 954a,b,c...n through which a single high strength filament 956 is passed.
  • Filament 956, which can be a high strength fiber, is interwoven in annular substrate 958, which can have the same construction as substrate 758 or any other suitable substrate.
  • Annular substrate 958 can then be coupled to a tubular substrate such as substrate 206.
  • Covered stent 800 also includes one or more stents 980, which can have the same configuration as stents 202a-c and can be interwoven into the mesh substrate to which substrate 958 is coupled in the same manner as stents 202a-c are interwoven into braid-type mesh substrate 206.
  • the stent, bare spring, and substrate assembly is then encapsulated with a polymer using any suitable process such as electrospinning or dip coating.
  • any of the covered stents described herein can have a bifurcated configuration suitable for treating abdominal aortic aneurysms.
  • Any feature described in any one embodiment described herein can be combined with any other feature or features of any of the other embodiments or features described herein.
  • variations and modifications of the devices and methods disclosed herein will be readily apparent to persons skilled in the art.

Landscapes

  • Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

A covered stent comprises a substrate, a stent adapted to be placed in a lumen of a human body, where the stent has portions interwoven in the substrate, and encapsulation encapsulating the substrate and the portions of the stent interwoven in the substrate and forming a tubular graft member

Description

COVERED STENT AND METHOD OF MAKING SAME
FIELD OF THE INVENTION
[0001] The invention relates to encapsulated stents suitable for placement in a human body lumen such as an artery.
BACKGROUND OF THE INVENTION
[0002] Tubular prostheses such as stents, grafts, and stent-grafts (e.g., stents having an inner and/or outer covering comprising graft material and which may be referred to as covered stents) have been used to treat abnormalities in passageways in the human body. In vascular applications, these devices often are used to replace or bypass occluded, diseased or damaged blood vessels such as stenotic or aneurysmal vessels. For example, it is well known to use stent-grafts, which comprise biocompatible graft material (e.g., Dacron® or expanded polytetrafluoroethylene (ePTFE) or some other polymer) supported by a framework (e.g., one or more stent or stent-like structures), to treat or isolate aneurysms. The framework provides mechanical support and the graft material or liner provides a blood barrier. [0003] Aneurysms are an abnormal widening of a duct or canal such as a blood vessel and generally appear in the form of a sac formed by the abnormal dilation of the duct or vessel wall. The abnormally dilated wall typically is weakened and susceptible to rupture. Aneurysms can occur in blood vessels such as in the abdominal aorta where the aneurysm generally extends from a location below the renal arteries distally to or toward the iliac arteries.
[0004] In treating an aneurysm with a stent-graft, the stent-graft typically is placed so that one end of the stent-graft is situated proximally or upstream of the diseased portion of the vessel and the other end of the stent-graft is situated distally or downstream of the diseased portion of the vessel. In this manner, the stent-graft extends through (spans) the aneurysmal sac and beyond the proximal and distal ends thereof to replace or bypass the weakened portion. The graft material typically forms a blood impervious lumen to facilitate endovascular exclusion of the aneurysm. [0005] Approaches for making stent-grafts such as abdominal aortic aneurysm stent- grafts have included sewing annular metallic spring elements, which may have a sinusoidal configuration, to woven materials described above such as expanded polytetrafluoroethylene, polytetrafluoroethylene, or Dacron® fabric. Other approaches have included electrospinning the stent structure with a polymer or dip coating the stent structure with a polymer. One example of a known polymeric coated stent-graft is illustrated in FIG. 1 , where covered stent 100 comprises metallic springs or undulating elements 102a, 102b, 102c and 102d, which can be referred to as stents or stent elements. In this example, stents or stent elements 102a, 102b, 102c and 102d have been treated with an electrospinning or dip coating process to form tubular polymeric graft member 104, which is adhered thereto. Although electrospinning and dip coating techniques may provide stent-grafts with lower profiles, there is a relatively low contact surface area between the stents and the polymeric material and the line of contact or adhesion between the stent and the polymeric material also may not be uniform throughout the circumference of the stent resulting in non-uniform load distribution when a force is placed on the stent-graft, which can result in delamination. The materials used also can be a factor in creating a tendency for the polymeric membrane and stent to delaminate. An example of separation or detachment between the stent wire and polymeric membrane is diagrammatically depicted and designated with reference character D1 in FIG. 1. Delamination typically is more of a concern in areas of higher stress loading such as the connections between the polymeric graft material and bare spring that extend beyond the edge of the polymeric graft material as shown in FIG. 2. FIG. 2 illustrates a covered stent 110 having a known construction including a plurality of metallic undulating annular stent elements 112a, 112b, 112c ...112n and annular undulating bare wire spring 116. A known electrospinning or dip coating process is used to provide the stent elements with a tubular polymeric graft 114 and to secure the apexes at one end of bare spring 116 to the graft. In this example, the apexes, which can be subjected to higher stresses than the stent elements, can detach as diagrammatically shown for example with reference character D2. [0006] There remains a need to develop and/or improve stent-graft constructions.
SUMMARY OF THE INVENTION
[0007] The present invention involves improvements in covered stent construction. [0008] In one embodiment according to the invention, a covered stent suitable for placement in a lumen in a human body (e.g., an artery) comprises a substrate; a tubular stent adapted to be placed in a lumen of a human body, the stent having portions interwoven in the substrate; and encapsulation encapsulating the substrate and the portions of the stent interwoven in the and forming tubular graft member. [0009] In another embodiment according to the invention, a covered stent suitable for placement in a lumen in a human body comprises a substrate; a plurality of stents adapted to be placed in a lumen of a human body, the stents having portions interwoven in the substrate; and a tubular polymeric member covering the stents and extending through at least a portion of the substrate.
[0010] In another embodiment according to the invention, a method of making a covered stent comprises interweaving a wire though a substrate to form a tubular member; and encapsulating the tubular member to form a covered stent having a tubular cover.
[0011] The above is a brief description of some deficiencies in the prior art and advantages of embodiments according to the present invention. Other features, advantages, and embodiments according to the present invention will be apparent to those skilled in the art from the following description and accompanying drawings, wherein, for purposes of illustration only, specific embodiments are set forth in detail.
BRIEF DESCRIPTION OF THE DRAWINGS [0012] FIG. 1 illustrates a known covered stent configuration. [0013] FIG. 2 illustrates a portion of another known covered stent configuration. [0014] FIG. 3A is a cut away view of a covered stent embodiment according to the invention with a portion of the cover removed to show a stent element and a substrate in which it is integrated.
[0015] FIG. 3B1 is a sectional view taken along line 3B1-3B1 in FIG. 3A and diagrammatically illustrating locations in the tubular substrate where the annular stent is interwoven.
[0016] FIG. 3B2 is a sectional view taken through a portion of one of the stents of FIG. 3A showing the substrate and cover material
[0017] FIG. 3C is a close up view illustrating a variation of the substrate-stent configuration shown in FIG. 3A.
[0018] FIG. 3D is a close up view illustrating another variation of the substrate-stent configuration shown in FIG. 3A.
[0019] FIG. 4 is a close up view illustrating a stent-graft substrate and a bare wire spring integrated therein according to another embodiment of the invention. [0020] FIG. 5A illustrates a known anchoring mechanism.
[0021] FIG. 5B illustrates a portion of a covered stent with the anchoring mechanism of FIG. 5A integrated therein. [0022] FIG. 6 is a partial sectional view of a portion of a covered stent with an anchor element secured thereto.
[0023] FIG. 7 is a partial sectional view of a portion of a covered stent with an anchor element secured thereto.
[0024] FIGS. 8A and 8B illustrate assembly of another covered stent embodiment according to the invention, where FIG. 8A illustrates an anchoring attachment component for the covered stent and FIG. 8B illustrates the anchoring attachment component integrally formed in a covered stent according to another embodiment.
DETAILED DESCRIPTION
[0025] The following description will be made with reference to the drawings where when referring to the various figures, it should be understood that like numerals or characters indicate like elements. Further, when referring to catheters, delivery devices, and loaded fasteners described below, the proximal end is the end nearest the operator and the distal end is farthest from the operator.
[0026] The invention generally involves a method of incorporating one or more stent and/or anchor structures into a polymeric membrane, which can be formed, for example, through known electrospinning or dip coating techniques. The stent or stents or at least a portion thereof are integrally incorporated into a material, which can be referred to as a substrate, and the integrated construction partially or wholly encapsulated (e.g., in a polymer such as polyurethane) by known electrospinning or dip coating techniques.
[0027] According to one embodiment, the substrate material can be loose textile mesh constructed from an open weave, knit, or braid. The textile mesh should be sufficiently open to easily allow the polymer to flow through it during the electrospinning or dip coating process. In the case of wire stents, incorporating or integrating the stent into the substrate material can be accomplished by passing an end of the stent wire back and forth through mesh in an annular direction and then crimping the free ends of the wire together to form an annular stent element. All of the wire need not be weaved in and out of the mesh as will be described in more detail below. Other methods of integrating the stent and mesh material include weaving or knitting the mesh around the entire stent or at least a portion of the stent. The integrated stent-substrate construction is then encapsulated or coated using, for example, a known stent electrospinning or dip coating process, to form the polymeric membrane stent cover. The stent cover provides a fluid barrier that is suitable as for use as a graft in a lumen in a human patient. Typically the cover will provide a continuous blood impervious surface suitable for use in an artery in a human patient. [0028] One of the many advantages of this construction is that if the stent becomes completely delaminated from the polymeric membrane formed with the foregoing process, it remains attached by the polymer mesh (polymer mesh is a loose weave, braid, or knit. Further, the substrate or mesh can better distribute the load of the stent through the membrane as compared to a stent without such a substrate. The polymeric material also can be selected to improve the bonding or adhesion between the stent-substrate and the polymeric material.
[0029] The mesh substrate has a loose construction suitable for weaving the stent wire in and out of the substrate. It can be a very open weave, knit or braid. Knitted meshes typically offer more flexibility and weaves typically offer more dimensional stability. The substrate mesh can be made from a variety of materials including polyester, UHMWPE, liquid crystal polymers, and Kevlar.
[0030] Referring to FIG. 3A, a covered stent according to one embodiment of the invention is shown in cut away view so that the substrate can be seen. In the illustrative example, covered stent 200 is shown with three stents 202a, 202b and 202c. It should be understood, however, that more or fewer stents can be used. The stents are shown with undulating annular configurations where each undulation has two leg portions which converge at an apex. The number of undulations can vary depending on the size of the stent and the application and in this example there are four undulations where two are hidden from view. In this embodiment, one of each of the two leg portions (of the undulating stent) is interwoven into the material and the other is not woven into the material and is adjacent to the inner surface or outer surface of mesh substrate 206. FIG. 3A depicts descending legs 208a and 208b interwoven in mesh substrate 206 in which appears as dashed lines, while ascending legs 209a and 209b are shown positioned along the outer surface of the substrate. The other undulating portions are similarly integrated with mesh substrate 206, but hidden from view. Thus, every other leg is interwoven into the substrate when moving in an annular or circumferential direction as diagrammatically shown in FIG. 3B1. In the variation shown in FIG. 3C, an oppositely configured pattern is used. Legs 209a, 209b, and 209c are interwoven into mesh substrate 206, while legs 208a, 208b, 208c are outside the mesh substrate prior to electrospinning or dip coating (the remaining legs forming the annular stent are hidden from view. In the variation shown in FIG. 3D, all legs of each undulation are interwoven into the mesh substrate before electrospinning or dip coating (five legs are shown in this figure with the remaining legs forming the annular stent being hidden from view).
[0031] Referring to FIG. 3B2, a sectional view of a portion of stent 200 is shown depicting stent wire 202c between two layers of polymeric material 204 on opposite sides of the mesh substrate. A noted above, the mesh substrate is sufficiently open so as to allow the polymer to pass therethrough during the electrospinning or dip coating process.
[0032] Referring to FIG. 4, another embodiment is shown where undulating bare spring wire 510 is integrated with mesh substrate 506 before electrospinning or dip coating. The apex portions at one end of the bare spring are interwoven in mesh substrate 506. The apex portions are shown encircled and numbered 512a, 512b, and 512c. Stent elements can be provided as described in any of the embodiments disclosed herein.
[0033] Referring to FIGS. 5A and 5B, integration of an anchor into a covered stent will be described. FIG. 5A depicts a known stent-graft anchor 600 having a barb support member or cage 602 with a plurality of barbs 604a,b,c,d extending from or secured to end portions along one side thereof. Wires or posts 606a,b,c,d having eyelets or loops 608a,b,c,d at their free ends extend from or are attached to the other side of the cage. Referring to FIG. 5B, the anchor is secured to covered stent 650 having one or more stents 652 integrated therein using a substrate as described above. The anchor is secured to the substrate with a plurality of high strength filaments 654a,b...n that are looped through eyelets 608a,b...n. The filaments, each of which can be a high strength fiber, are interwoven in the substrate along a portion of the length of the substrate such as shown in detail in FIG. 6 before the stent, substrate and eyelets are encapsulated in a polymer by way of, for example, an electrospinning or dip coating process to provide a tubular covered stent that is impervious to blood flow through the tubular cover. The substrate can run the entire length of the covered stent in this embodiment or any other embodiment described herein and the filaments can be interwoven along the entire length of the substrate to maximize filament incorporation or integration with the cover or polymeric membrane 656, which can comprise, for example, any of the materials described above. However, the substrate need not run the entire length of the covered stent and the filaments need not extend the entire length of the substrate. In another embodiment, the free ends of the filament can be adhered, tied otherwise secured to the substrate. Anchor 600 and the bare springs described below typically are attached to the proximal end of the covered stent, which is the end closest to the heart by reference to blood flow path when the covered stent is positioned in situ.
[0034] Referring to FIG. 6, another covered stent embodiment 700 is shown where a bare coil spring 750 with posts 752a,b,c...n extending therefrom and including eyelets 754a,b,c...n is secured to the covered stent in the same manner as anchor 600 is secured to covered stent 650. Each of a plurality of high strength filaments 756a,b...n, each of which can be a high strength fiber, are passed through a respective eyelet and interwoven in the mesh substrate that extends the entire length and the entire circumference of the covered stent. Covered stent 700 is shown in partial section with a portion of polymeric layer or cover 757 removed to show a portion of substrate 758 in an enlarged manner to illustrate filament 756b interwoven therein. Substrate 758 has a plurality of interwoven threads that can be interlaced like the warp and weft of a woven fabric. It should be understood that mesh patterns in all of the embodiments described herein are interchangeable and further that other patterns can be used as the illustrative embodiments are provided for the purposes of example and not to limit the scope of of possible options. Covered stent 700 also includes one or more stents 780 which can have the same configuration as stents 202a-c and can be interwoven into mesh substrate 758 in the same manner as stents 202a-c are interwoven into braid-type mesh substrate 206.
[0035] Referring to FIG. 7, another covered embodiment 800, which is the same as covered stent 700 with the exception that the securing filament pattern differs. Bare spring 850 can have the same construction as bare spring 750 with eyelets 854a,b,c...n through which high strength filaments 856a,b,c...n are passed. Filaments 856a, b, c... n are interwoven in substrate 858, which can have the same construction as substrate 758 or any other suitable substrate. Covered stent 800 is shown in partial section with a portion of polymeric layer or cover 857 removed to show a portion of substrate 858 in an enlarged manner to illustrate filaments 856a and 856c interwoven therein. In the illustrative embodiment, each filament has one portion that extends in a clockwise helical direction and another portion that extends in a counterclockwise helical direction. The filaments in this embodiment can improve load distribution from the eyelets. Although not shown, covered stent 800 also includes one or more stents, which can have the same configuration as stents 202a-c and can be interwoven into mesh substrate 858 in the same manner as stents 202a-c are interwoven into braid-type mesh substrate 206. [0036] Referring to FIGS. 8A and 8B, another covered stent embodiment 900 according to the invention is shown, where FIG. 8A illustrates an anchor and attachment component of covered stent 900 and FIG. 8B illustrates the anchor and attachment component integrally formed in the covered stent using electrospinning or dip coating techniques. Referring to FIG. 8A, bare spring 950 has the same construction as bare spring 750 and includes eyelets 954a,b,c...n through which a single high strength filament 956 is passed. Filament 956, which can be a high strength fiber, is interwoven in annular substrate 958, which can have the same construction as substrate 758 or any other suitable substrate. Annular substrate 958 can then be coupled to a tubular substrate such as substrate 206. Covered stent 800 also includes one or more stents 980, which can have the same configuration as stents 202a-c and can be interwoven into the mesh substrate to which substrate 958 is coupled in the same manner as stents 202a-c are interwoven into braid-type mesh substrate 206. The stent, bare spring, and substrate assembly is then encapsulated with a polymer using any suitable process such as electrospinning or dip coating. [0037] Although not shown, any of the covered stents described herein can have a bifurcated configuration suitable for treating abdominal aortic aneurysms. [0038] Any feature described in any one embodiment described herein can be combined with any other feature or features of any of the other embodiments or features described herein. Furthermore, variations and modifications of the devices and methods disclosed herein will be readily apparent to persons skilled in the art.

Claims

What Is Claimed Is:
1. A covered stent suitable for placement in a lumen in a human body comprising: a substrate; a stent adapted to be placed in a lumen of a human body, said stent having portions interwoven in said substrate; and encapsulation encapsulating said substrate and the portions of said stent interwoven in said substrate and forming a tubular graft member.
2. The covered stent of claim 1 wherein said substrate has a tubular shape.
3. The covered stent of claim 1 wherein said substrate extends less than the entire length of the tubular graft member.
4. The covered stent of claim 1 wherein said substrate extends the entire length of the tubular graft member.
5. The covered stent of claim 1 wherein said substrate comprises mesh material.
6. The covered stent of claim 5 wherein said encapsulation extends through the mesh material.
7. The covered stent of claim 1 wherein said encapsulation comprises polymeric material.
8. The covered stent of claim 7 wherein said encapsulation is formed through an electrospinning process.
9. The covered stent of claim 7 wherein said encapsulation is formed through s a dip coating process.
10. The covered stent of claim 1 including a plurality of said stents where each of said stents is interwoven in said substrate.
11. The covered stent of claim 1 wherein said tubular graft forms a wall that is impervious to blood flow therethrough.
12. The covered stent of claim 1 further including an anchor member and at least one filament, said filament extending through a portion of said anchor member and being interwoven in said substrate.
13. The covered stent of claim 1 wherein said anchor member has barbs extending therefrom.
14. The covered stent of claim 1 further including a bare spring and at least one filament, said filament extending through a portion of said bare spring and being interwoven in said substrate.
15. A covered stent suitable for placement in a lumen in a human body comprising: a substrate; a plurality of stents adapted to be placed in a lumen of a human body, said stents having portions interwoven in said substrate; and a tubular polymeric member covering said stents and extending through at least a portion of said substrate.
16. The covered stent of claim 15 wherein said substrate comprises mesh.
17. The covered stent of claim 15 further including an anchor and a filament secured to the anchor and said substrate.
18. The covered stent of claim 15 wherein said anchor comprises a bare spring element.
19. The covered stent of claim 15 wherein said anchor has a barb extending therefrom.
20. A method of making a covered stent comprising: interweaving a wire though a substrate to form a tubular member; encapsulating the tubular member to form a covered stent having a tubular cover suitable for placement in a lumen of a human body.
21. The method of claim 20 wherein encapsulating comprises electrospinning a polymer over the stent and substrate.
22. The method of claim 20 wherein encapsulating comprises dipping the stent and substrate in polymeric material.
EP09728421A 2008-03-31 2009-03-03 Covered stent and method of making Withdrawn EP2271280A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/059,541 US20090248131A1 (en) 2008-03-31 2008-03-31 Covered Stent and Method of Making Same
PCT/US2009/035901 WO2009123814A1 (en) 2008-03-31 2009-03-03 Covered stent and method of making

Publications (1)

Publication Number Publication Date
EP2271280A1 true EP2271280A1 (en) 2011-01-12

Family

ID=40585128

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09728421A Withdrawn EP2271280A1 (en) 2008-03-31 2009-03-03 Covered stent and method of making

Country Status (4)

Country Link
US (1) US20090248131A1 (en)
EP (1) EP2271280A1 (en)
JP (1) JP2011516156A (en)
WO (1) WO2009123814A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8795577B2 (en) 2007-11-30 2014-08-05 Cook Medical Technologies Llc Needle-to-needle electrospinning
JP5300987B2 (en) 2009-01-16 2013-09-25 ゼウス インダストリアル プロダクツ, インコーポレイテッド Electrospinning of PTFE containing high viscosity materials
US20130268062A1 (en) 2012-04-05 2013-10-10 Zeus Industrial Products, Inc. Composite prosthetic devices
JP5456892B2 (en) 2009-08-07 2014-04-02 ゼウス インダストリアル プロダクツ インコーポレイテッド Multilayer composite
US8637109B2 (en) * 2009-12-03 2014-01-28 Cook Medical Technologies Llc Manufacturing methods for covering endoluminal prostheses
US8808353B2 (en) 2010-01-30 2014-08-19 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds having a low crossing profile
US8568471B2 (en) 2010-01-30 2013-10-29 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds
US8512393B2 (en) * 2010-02-26 2013-08-20 ProMed, Inc. Apparatus for vessel access closure
US9345602B2 (en) 2010-09-23 2016-05-24 Abbott Cardiovascular Systems Inc. Processes for making crush recoverable polymer scaffolds
CN102782196A (en) 2010-10-14 2012-11-14 宙斯工业产品股份有限公司 Antimicrobial Substrate
CN103561682A (en) * 2011-01-28 2014-02-05 梅瑞特医药体系股份有限公司 Electrospun PTFE coated stents and methods of use thereof
US9114000B2 (en) 2011-03-14 2015-08-25 Cook Medical Technologies Llc Apparatus and methods to enhance bonding in endoluminal prostheses
US9060852B2 (en) 2011-04-08 2015-06-23 Cook Medical Technologies Llc Method for making a flexible stent-graft
US9173736B2 (en) * 2011-04-28 2015-11-03 Medtronic Vascular, Inc. Method of making an endoluminal vascular prosthesis
US8726483B2 (en) 2011-07-29 2014-05-20 Abbott Cardiovascular Systems Inc. Methods for uniform crimping and deployment of a polymer scaffold
US20150230918A1 (en) 2011-08-16 2015-08-20 The University Of Kansas Biomaterial based on aligned fibers, arranged in a gradient interface, with mechanical reinforcement for tracheal regeneration and repair
US20130289690A1 (en) * 2011-11-01 2013-10-31 Hira V. Thapliyal Personalized prosthesis and methods of use
US9175427B2 (en) 2011-11-14 2015-11-03 Cook Medical Technologies Llc Electrospun patterned stent graft covering
KR102037543B1 (en) 2012-01-16 2019-10-28 메리트 메디컬 시스템즈, 인크. Rotational spun material covered medical appliances and methods of manufacture
US8911490B2 (en) * 2012-03-27 2014-12-16 Medtronic Vascular, Inc. Integrated mesh high metal to vessel ratio stent and method
US9192462B2 (en) 2012-04-06 2015-11-24 Trivascular, Inc. Low profile stent graft and delivery system
EP2833829B1 (en) * 2012-04-06 2019-11-06 TriVascular, Inc. Low profile stent graft and delivery system
US9254212B2 (en) 2012-04-06 2016-02-09 Abbott Cardiovascular Systems Inc. Segmented scaffolds and delivery thereof for peripheral applications
US8834556B2 (en) 2012-08-13 2014-09-16 Abbott Cardiovascular Systems Inc. Segmented scaffold designs
US11541154B2 (en) 2012-09-19 2023-01-03 Merit Medical Systems, Inc. Electrospun material covered medical appliances and methods of manufacture
US9198999B2 (en) 2012-09-21 2015-12-01 Merit Medical Systems, Inc. Drug-eluting rotational spun coatings and methods of use
US10154918B2 (en) 2012-12-28 2018-12-18 Cook Medical Technologies Llc Endoluminal prosthesis with fiber matrix
US9827703B2 (en) 2013-03-13 2017-11-28 Merit Medical Systems, Inc. Methods, systems, and apparatuses for manufacturing rotational spun appliances
WO2014159710A1 (en) 2013-03-13 2014-10-02 Merit Medical Systems, Inc. Serially deposited fiber materials and associated devices and methods
CN105213076A (en) * 2014-06-12 2016-01-06 微创心脉医疗科技(上海)有限公司 A kind of artificial tumor neck and preparation method thereof
EP3261589B1 (en) 2015-02-26 2020-09-16 Merit Medical Systems, Inc. Layered medical appliances
EP3285687A4 (en) 2015-04-22 2019-07-10 AneuMed, Inc. PERSONALIZED PROSTHESIS AND DEPLOYMENT METHODS
KR102038317B1 (en) * 2017-11-21 2019-10-30 주식회사 티티엔지 Golf cart system capable of autonomous travel based on accurate position information and golf cart control method using the system
EP4297813A4 (en) 2021-02-26 2025-01-15 Merit Medical Systems, Inc. FIBROUS CONSTRUCTIONS WITH THERAPEUTIC MATERIAL PARTICLES
WO2023125434A1 (en) * 2021-12-31 2023-07-06 元心科技(深圳)有限公司 Covered stent system and preparation method therefor
CN116687634B (en) * 2023-07-24 2023-11-03 上海宏普医疗器械有限公司 Puncture tectorial membrane support that ultrasonic wave was carried down

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433617T2 (en) * 1993-09-30 2005-03-03 Endogad Research Pty Ltd. INTRALUMINAL TRANSPLANT
DE69732794T2 (en) * 1996-01-05 2006-04-06 Medtronic, Inc., Minneapolis EXPANDABLE ENDOLUMINARY PROSTHESIS
US6156064A (en) * 1998-08-14 2000-12-05 Schneider (Usa) Inc Stent-graft-membrane and method of making the same
US6159239A (en) * 1998-08-14 2000-12-12 Prodesco, Inc. Woven stent/graft structure
US6849088B2 (en) * 1998-09-30 2005-02-01 Edwards Lifesciences Corporation Aorto uni-iliac graft
US6368345B1 (en) * 1998-09-30 2002-04-09 Edwards Lifesciences Corporation Methods and apparatus for intraluminal placement of a bifurcated intraluminal garafat
EP1121066B1 (en) * 1999-01-22 2006-05-17 Gore Enterprise Holdings, Inc. Covered endoprosthesis
US6287335B1 (en) * 1999-04-26 2001-09-11 William J. Drasler Intravascular folded tubular endoprosthesis
DE20115706U1 (en) * 2001-09-25 2001-12-13 Curative Ag Arrangement for implantation in an aorta
US7708771B2 (en) * 2002-02-26 2010-05-04 Endovascular Technologies, Inc. Endovascular graft device and methods for attaching components thereof
WO2003087443A1 (en) * 2002-04-11 2003-10-23 Secant Medical, Inc. Covering process using electrospinning of very small fibers
US20050008588A1 (en) * 2003-06-05 2005-01-13 L'oreal Aminoarylvinyl-s-triazine compounds and uses thereof
US7192440B2 (en) * 2003-10-15 2007-03-20 Xtent, Inc. Implantable stent delivery devices and methods
WO2005070337A2 (en) * 2004-01-20 2005-08-04 Cook Incorporated Endoluminal stent graft with sutured attachment
US8172895B2 (en) * 2005-08-18 2012-05-08 Cook Medical Technologies Llc Design and assembly of fenestrated stent grafts
US20080306580A1 (en) * 2007-02-05 2008-12-11 Boston Scientific Scimed, Inc. Blood acess apparatus and method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2009123814A1 *

Also Published As

Publication number Publication date
US20090248131A1 (en) 2009-10-01
WO2009123814A1 (en) 2009-10-08
JP2011516156A (en) 2011-05-26

Similar Documents

Publication Publication Date Title
US20090248131A1 (en) Covered Stent and Method of Making Same
US10159560B2 (en) Prosthesis having pivoting fenestration
EP2499997B1 (en) Endoluminal prostheses
US10265200B2 (en) Medical prostheses having bundled and non-bundled regions
EP0880949B1 (en) Bifurcated stent graft
US9173736B2 (en) Method of making an endoluminal vascular prosthesis
JP7223703B2 (en) Multi-layered endoluminal prosthesis assembly and manufacturing method
US20120221096A1 (en) Prosthesis having pivoting fenestration
WO2010024849A1 (en) Prosthesis with moveable fenestration
JP2012040394A (en) Prosthesis having pivoting fenestration
CN103908356A (en) Prosthesis having pivoting fenestration
US11690705B2 (en) Graft having a pocket for receiving a stent and woven graft material, forming a pocket
JP7774045B2 (en) Vascular stent graft
WO2013130390A1 (en) Prosthesis
CN119365150A (en) Sutureless stent graft with integrated extension and stent graft structure and method of forming the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20101028

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20110616